Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight
PHASE1
Neladenoson bialanate is currently under clinical development for a conditi...
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PHASE2
Background:
* Growth of new blood vessels (angiogenesis) provides many tum...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma
PHASE1
This first time in human (FTIH) open-label, dose escalation study will asse...